IOTA-ADNEX超声模型与ADNEX MR评分系统在high-risk患者卵巢癌诊断中的前瞻性比较研究
该前瞻性单中心研究纳入342例一线超声提示附件包块恶性风险的患者,头对头比较IOTA-ADNEX超声模型与ADNEX MR评分系统的诊断效能。结果显示两者鉴别良恶性的AUC分别为0.96和0.93,诊断准确性相当,均可作为二线评估手段。
要点
- IOTA-ADNEX与ADNEX MR对附件包块良恶性鉴别准确性相当,AUC分别为0.96与0.93。
- 两方法在识别关键形态学特征上一致性中等至高度(κ=0.46-0.75)。
- IOTA-ADNEX在鉴别交界性肿瘤与I期浸润癌时效能降低(AUC=0.71)。
核心结论
- IOTA-ADNEX模型与ADNEX MR评分系统在鉴别附件包块良恶性方面诊断准确性相当。
- 按病变形态分层后两者结果一致,均可作为一线超声提示风险患者的二线评估手段。
研究设计与样本
- 前瞻性单中心诊断准确性研究,采用头对头比较设计,于丹麦Aarhus大学医院三级转诊中心进行。
- 纳入2021年5月至2022年12月一线影像怀疑附件恶性的患者342例(分析342个病灶)。
- 所有患者接受系统性专家超声检查(含IOTA-ADNEX风险估计)及系统性MRI扫描(由专家放射科医师赋值ADNEX MR评分)。
- 超声检查者与放射科医师对彼此影像结果及参考标准(肿瘤结局)设盲。
- 参考标准为原发附件包块的组织病理学诊断,少数病例采用临床随访;交界性肿瘤、浸润性附件恶性肿瘤及附件转移归为恶性。
关键影像表现/征象
- 超声与MRI在关键形态学特征识别上一致性中等至高度(κ=0.46-0.75)。
- 病灶大小测量一致性良好至优秀(ICC=0.78-0.92)。
- IOTA-ADNEX模型校准良好。
- IOTA-ADNEX模型对肿瘤亚型的多项判别能力总体较高,但鉴别交界性肿瘤与I期浸润癌时效能降低(AUC=0.71,95%CI 0.56-0.82)。
诊断标准与关键数值
- IOTA-ADNEX模型鉴别良恶性附件肿瘤的AUC为0.96(95%CI 0.94-0.98),含或不含CA 125结果相同。
- ADNEX MR评分系统鉴别良恶性附件肿瘤的AUC为0.93(95%CI 0.91-0.96)。
- 队列中绝经后患者占78.1%,恶性患病率为58.8%。
临床应用与阅片要点
- 对于一线超声提示恶性风险的附件包块,可依据本中心资源选择IOTA-ADNEX或ADNEX MR作为二线评估。
- 两种方法在病变形态和大小分层后结果一致,阅片时无需因病灶特征偏好某一模态。
- 需注意IOTA-ADNEX在交界性肿瘤与I期浸润癌鉴别中效能有限,报告时应结合临床及其他信息综合判断。
局限性
- 单中心研究,结果外推需多中心验证。
- 恶性患病率较高(58.8%),可能影响诊断准确性的评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To systematically validate and compare ultrasonography, using the ultrasound-based International Ovarian Tumor Analysis - Assessment of Different NEoplasias in the adneXa (IOTA-ADNEX) model, with magnetic resonance imaging (MRI), using the MRI-based ADNEX MR scoring system, as second-line imaging modalities for estimating the risk of adnexal malignancy in patients identified as being at risk of malignancy on first-line ultrasound examination.
METHODS: This was a prospective, single-center diagnostic accuracy study designed as a head-to-head comparison. All patients referred to a tertiary referral center at Aarhus University Hospital, Aarhus, Denmark, for suspected adnexal malignancy on first-line imaging between May 2021 and December 2022 were offered second-line diagnostic testing. This comprised both a systematic expert ultrasound examination, including IOTA-ADNEX risk estimation, and a systematic MRI scan with ADNEX MR scores assigned by expert radiologists. The imaging assessments were performed prospectively, with ultrasound examiners and radiologists blinded to the results of other imaging modalities and to the reference standard (tumor outcome). The reference standard was a histopathological diagnosis of the primary adnexal mass or, in a small number of cases, clinical follow-up. Borderline tumors, invasive adnexal malignancy and metastases to the adnexa were grouped as malignancies. Diagnostic performance of the IOTA-ADNEX model, ADNEX MR scoring system and CA 125 for predicting malignancy was evaluated using the area under the receiver-operating-characteristics curve (AUC), and AUCs were compared using DeLong's test. Diagnostic metrics were estimated at clinically relevant cut-offs and scores. Agreement between modalities was assessed for the identification of morphological features and overall risk estimation using Cohen's kappa statistics, intraclass correlation coefficients (ICC) and Bland-Altman plots. For the IOTA-ADNEX model, calibration and the ability to discriminate between tumor subtypes were evaluated.
RESULTS: The included cohort comprised 342 patients (342 lesions analyzed). In the final cohort, 78.1% of patients were postmenopausal and the overall prevalence of malignancy was 58.8%. The AUC for distinguishing patients with benign tumors from those with malignant tumors was 0.96 (95% CI, 0.94-0.98) for the IOTA-ADNEX model (with or without CA 125) compared with an AUC of 0.93 (95% CI, 0.91-0.96) for ADNEX MR. Agreement between ultrasound and MRI ranged from moderate to substantial for key morphological features (κ = 0.46-0.75) and from good to excellent for lesion-size measurements (ICC = 0.78-0.92). The IOTA-ADNEX model performed similarly to the ADNEX MR scoring system regardless of lesion morphology or size. The IOTA-ADNEX model had good calibration. Furthermore, its multinomial discriminative ability between tumor subtypes was generally high, although performance was reduced when distinguishing borderline tumors from Stage-I invasive malignancy (AUC, 0.71 (95% CI, 0.56-0.82)).
CONCLUSIONS: The IOTA-ADNEX model and ADNEX MR scoring system demonstrated comparable diagnostic accuracy for differentiating benign from malignant adnexal masses in this study. Results appeared to be consistent when stratified by lesion morphology. Both modalities may be used for second-line assessment of masses deemed at risk of malignancy in the first-line ultrasound examination, depending on resources in specific centers. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Dueholm Hjorth IM, Ledger A, Møller C, et al. Ultrasonography (IOTA-ADNEX) vs magnetic resonance imaging (ADNEX MR) for diagnosing ovarian cancer in high-risk patients: a prospective study. Ultrasound Obstet Gynecol. 2026. PMID: 42954917. doi:10.1002/uog.70368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。